23 days ago
IMNM
AnalystsMichael SchmidtMichael Schmidt's Stock Forecasts
AnalystsMichael Schmidt
Analyst Ranking
Top 2%
#84 out of 5165 analysts
Average Return
+50.25%
Win Rate
67%66 out of 98
Risk vs Reward
Poor
Good
Michael Schmidt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nanobiotix SaNBTX | +557.89% | $3.27 | $21.48 | 2025-04-03 - 2026-01-07 | Strong Buy |
Urogen Pharma LtdURGN | +452.27% | $4.19 | $23.14 | 2025-05-22 - 2026-01-07 | Strong Buy |
Mersana Therapeutics IncMRSN | +291.91% | $7.42 | $29.08 | 2025-08-13 - 2026-01-05 | Strong Buy |
Cogent Biosciences IncCOGT | +270.86% | $9.78 | $36.27 | 2025-07-07 - 2026-01-07 | Strong Buy |
Mersana Therapeutics IncMRSN | +242.04% | $8.50 | $29.08 | 2025-05-15 - 2026-01-05 | Strong Buy |
Michael Schmidt Analyst Color
Get additional color on Michael Schmidt's coverage of popular stocks
5 months ago
CMPX
7 months ago
ADCT
9 months ago
VSTM
a year ago
RVMD
a year ago
EXEL
2 years ago
EXEL
2 years ago
SNDX
3 years ago
ONC
4 years ago
ACET
Michael Schmidt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunome IncIMNM | 4 | Strong Buy | $35.00 | +75.18% | Maintains | 23 days ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $12.00 | +128.14% | Initiates Coverage On | 2 months ago |
Incyte CorpINCY | 5 | Strong Buy | $125.00 | +13.05% | Upgrades | 2 months ago |
Genmab AGMAB | 1 | Strong Buy | $43.00 | +26.84% | Upgrades | 4 months ago |
Mersana Therapeutics IncMRSN | 4 | Strong Buy | $30.00 | +3.16% | Maintains | 5 months ago |
Adc Therapeutics SaADCT | 5 | Strong Buy | $10.00 | +173.97% | Reiterates | 5 months ago |
Oric Pharmaceuticals IncORIC | 3 | Strong Buy | $18.00 | +107.37% | Reiterates | 5 months ago |
Compass Therapeutics IncCMPX | 4 | Strong Buy | $12.00 | +120.18% | Maintains | 5 months ago |
Beone Medicines LtdONC | 7 | Strong Buy | $365.00 | +9.32% | Maintains | 5 months ago |
Arvinas IncARVN | 4 | Strong Buy | $15.00 | +20.87% | Maintains | 5 months ago |
Tango Therapeutics IncTNGX | 1 | Strong Buy | $10.00 | -15.18% | Maintains | 5 months ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $17.00 | -53.13% | Reiterates | 6 months ago |
Revolution Medicines IncRVMD | 4 | Strong Buy | $80.00 | -22.11% | Reiterates | 6 months ago |
Arrivent Biopharma IncAVBP | 2 | Strong Buy | $45.00 | +129.12% | Reiterates | 6 months ago |
Urogen Pharma LtdURGN | 1 | Strong Buy | $15.00 | -35.18% | Maintains | 8 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $52.00 | -32.19% | Reiterates | 8 months ago |
Springworks Therapeutics IncSWTX | 3 | Hold | $47.00 | +0.02% | Reiterates | 8 months ago |
Relay Therapeutics IncRLAY | 1 | Strong Buy | $10.00 | +22.25% | Maintains | 8 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $32.00 | +44.73% | Reiterates | 8 months ago |
Nanobiotix SaNBTX | 2 | Strong Buy | $8.00 | -62.76% | Maintains | 9 months ago |
Merus NvMRUS | 4 | Strong Buy | $109.00 | +21.11% | Reiterates | 9 months ago |
Adaptimmune Therapeutics PLCADAPY | 3 | Strong Buy | $1.75 | +3,140.74% | Maintains | 9 months ago |
Verastem IncVSTM | 2 | Strong Buy | $14.00 | +83.25% | Maintains | 9 months ago |
Exelixis IncEXEL | 6 | Strong Buy | $42.00 | -9.07% | Reiterates | a year ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $20.00 | N/A | Reiterates | a year ago |
Zentalis Pharmaceuticals IncZNTL | 3 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Adicet Bio IncACET | 4 | Strong Buy | $112.00 | N/A | Upgrades | a year ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $92.00 | N/A | Reiterates | 2 years ago |
Immunogen IncIMGN | 1 | Hold | $31.00 | N/A | Downgrades | 2 years ago |
Xencor IncXNCR | 2 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 4 | Strong Buy | $60.00 | N/A | Maintains | 2 years ago |
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $82.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 3 | Strong Buy | $170.00 | N/A | Reiterates | 3 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Neurogene IncNGNE | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Rubius Therapeutics IncRUBY | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Immuneering CorpIMRX | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 4 years ago |
Erasca IncERAS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Cellectis SaCLLS | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Bolt Biotherapeutics IncBOLT | 1 | Strong Buy | $840.00 | N/A | Initiates Coverage On | 5 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $39.00 | N/A | Maintains | 6 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Forty Seven IncFTSV | 1 | Strong Buy | $48.00 | N/A | Maintains | 6 years ago |
Bluebird Bio IncBLUE | 4 | Hold | N/A | N/A | Downgrades | 7 years ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $80.00 | N/A | Upgrades | 7 years ago |
Clovis Oncology IncCLVSQ | 2 | Hold | $30.00 | N/A | Initiates Coverage On | 7 years ago |
Five Prime Therapeutics IncFPRX | 1 | Buy | $24.00 | N/A | Reinstates | 7 years ago |
Array Technologies IncARRY | 1 | Buy | $20.00 | N/A | Maintains | 8 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | $87.00 | N/A | Downgrades | 8 years ago |
Arbutus Biopharma CorpABUS | 1 | Hold | $5.50 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.